Rejuve.Bio is an AI-driven therapeutics discovery company solving the problems for longevity and age-associated diseases. By using advanced Artificial Intelligence to combine data from the Methuselah Flies with data from people, Rejuve.Bio can shorten the drug discovery pipeline and rapidly develop novel therapeutics to help people live longer. We have two high-impact and novel data sources, as well as unique artificial intelligence technology. First and foremost, we are the sole owner of data from the Methuselah Flies (fruit flies) that have been bred for longevity. Second, because flies have a shorter life cycle, they can be tested for longevity much faster than other animal models. We have the unique ability to test multiple interventions and treatment combinations over the course of a fruit fly's life and in various aspects of their lives (e.g., mating, disease resistance). We also have quick access to Crowdsourced Human Data collected by a partner company, Rejuve Network.